2021
DOI: 10.21203/rs.3.rs-1201676/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Five-year retrospective hospital-based study on epidemiological data regarding human Leishmaniasis in West Kordofan state - Sudan

Abstract: Background Leishmaniasis is a parasitic zoonotic disease caused by the Leishmania parasites genus. The estimation of this disease is very important to inform the health care policymakers and the governments to applied proper health and economic policies. Thus, this study aimed, to find out the frequency and distribution of human leishmaniasis in West Kordofan state, based on sex and age during 5 years- Sudan. Methods Five years retrospective study from 2016 through 2020 was carried out using local hospital r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…The disease can manifest in different forms, such as cutaneous (CL), visceral (VL), mucocutaneous (MCL), or postkala-azar dermal leishmaniasis (PKDL), depending on the parasite species and the host immune response. Leishmaniasis is endemic in many regions of Sudan, with CL being the most common form and VL being mainly confined to the eastern, western, and southern parts of the country [4][5][6]. Leishmaniasis affects 98 countries in Europe, Africa, Asia, and America, with a high burden in 13 countries that account for over 90% of new cases [7,8].…”
Section: Introductionmentioning
confidence: 99%
“…The disease can manifest in different forms, such as cutaneous (CL), visceral (VL), mucocutaneous (MCL), or postkala-azar dermal leishmaniasis (PKDL), depending on the parasite species and the host immune response. Leishmaniasis is endemic in many regions of Sudan, with CL being the most common form and VL being mainly confined to the eastern, western, and southern parts of the country [4][5][6]. Leishmaniasis affects 98 countries in Europe, Africa, Asia, and America, with a high burden in 13 countries that account for over 90% of new cases [7,8].…”
Section: Introductionmentioning
confidence: 99%